Hoiby N
Biofilm. 2025; 9():100246.
PMID: 39811797
PMC: 11732244.
DOI: 10.1016/j.bioflm.2024.100246.
Mesinele J, Ruffin M, Guillot L, Boelle P, Corvol H
Sci Rep. 2024; 14(1):27036.
PMID: 39511324
PMC: 11543658.
DOI: 10.1038/s41598-024-77253-5.
Ravenel K, Guegan H, Gastebois A, Bouchara J, Gangneux J, Giraud S
Mycopathologia. 2024; 189(2):19.
PMID: 38407729
DOI: 10.1007/s11046-023-00818-x.
Lin W, Tsai T, Chuang P
Microorganisms. 2024; 12(2).
PMID: 38399667
PMC: 10891919.
DOI: 10.3390/microorganisms12020263.
Alsayed A, Abed A, Khader H, Hasoun L, Al Maqbali M, Al Shawabkeh M
Libyan J Med. 2024; 19(1):2307679.
PMID: 38290012
PMC: 10829809.
DOI: 10.1080/19932820.2024.2307679.
Iron bioavailability regulates Pseudomonas aeruginosa interspecies interactions through type VI secretion expression.
Haas A, Zemke A, Melvin J, Armbruster C, Hendricks M, Moore J
Cell Rep. 2023; 42(3):112270.
PMID: 36930643
PMC: 10586262.
DOI: 10.1016/j.celrep.2023.112270.
Pseudomonas aeruginosa in the Cystic Fibrosis Lung.
King J, Murphy R, Davies J
Adv Exp Med Biol. 2022; 1386:347-369.
PMID: 36258079
DOI: 10.1007/978-3-031-08491-1_13.
Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination.
Stone V, Utorova R, Butrym M, Sioofy-Khojine A, Hankaniemi M, Ringqvist E
iScience. 2022; 25(10):105070.
PMID: 36157581
PMC: 9490033.
DOI: 10.1016/j.isci.2022.105070.
Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.
Planet P
J Pediatric Infect Dis Soc. 2022; 11(Supplement_2):S23-S31.
PMID: 36069898
PMC: 9451014.
DOI: 10.1093/jpids/piac073.
First report on the prevalence of bacteria in cystic fibrosis patients (CF) in a tertiary care center in Saudi Arabia.
Banjar H, Ghawi A, AlMogarri I, Alhaider S, Alomran H, Hejazi A
Int J Pediatr Adolesc Med. 2022; 9(2):108-112.
PMID: 35663786
PMC: 9152558.
DOI: 10.1016/j.ijpam.2021.07.001.
Meteorological Factors Influence the Presence of Fungi in the Air; A 14-Month Surveillance Study at an Adult Cystic Fibrosis Center.
van Rhijn N, Coleman J, Collier L, Moore C, Richardson M, Bright-Thomas R
Front Cell Infect Microbiol. 2021; 11:759944.
PMID: 34900752
PMC: 8662344.
DOI: 10.3389/fcimb.2021.759944.
Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infection.
Hendricks M, Lane S, Melvin J, Ouyang Y, Stolz D, Williams J
Cell Rep. 2021; 34(4):108672.
PMID: 33503419
PMC: 7918795.
DOI: 10.1016/j.celrep.2020.108672.
Airway cholinergic history modifies mucus secretion properties to subsequent cholinergic challenge in diminished chloride and bicarbonate conditions.
Liao Y, Collins E, Guevara M, Schurmann V, Atanasova K, Bravo L
Exp Physiol. 2020; 105(10):1673-1683.
PMID: 32735372
PMC: 11413990.
DOI: 10.1113/EP088900.
Bacterial Community Interactions During Chronic Respiratory Disease.
Welp A, Bomberger J
Front Cell Infect Microbiol. 2020; 10:213.
PMID: 32477966
PMC: 7240048.
DOI: 10.3389/fcimb.2020.00213.
Influences of environmental exposures on individuals living with cystic fibrosis.
Szczesniak R, Rice J, Brokamp C, Ryan P, Pestian T, Ni Y
Expert Rev Respir Med. 2020; 14(7):737-748.
PMID: 32264725
PMC: 7424635.
DOI: 10.1080/17476348.2020.1753507.
Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections.
Secor P, Burgener E, Kinnersley M, Jennings L, Roman-Cruz V, Popescu M
Front Immunol. 2020; 11:244.
PMID: 32153575
PMC: 7047154.
DOI: 10.3389/fimmu.2020.00244.
Modulates the Antiviral Response of Bronchial Epithelial Cells.
Sorensen M, Kantorek J, Byrnes L, Boutin S, Mall M, Lasitschka F
Front Immunol. 2020; 11:96.
PMID: 32117250
PMC: 7025480.
DOI: 10.3389/fimmu.2020.00096.
Microbiology of Cystic Fibrosis Airway Disease.
Blanchard A, Waters V
Semin Respir Crit Care Med. 2019; 40(6):727-736.
PMID: 31887768
PMC: 7117079.
DOI: 10.1055/s-0039-1698464.
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
Palser S, Smith S, Nash E, Agarwal A, Smyth A
Cochrane Database Syst Rev. 2019; 12:CD012300.
PMID: 31845758
PMC: 6916140.
DOI: 10.1002/14651858.CD012300.pub2.
Airway Surface Liquid Has Innate Antiviral Activity That Is Reduced in Cystic Fibrosis.
Berkebile A, Bartlett J, Abou Alaiwa M, Varga S, Power U, McCray Jr P
Am J Respir Cell Mol Biol. 2019; 62(1):104-111.
PMID: 31242392
PMC: 6938132.
DOI: 10.1165/rcmb.2018-0304OC.